Search Results

Raul Gainetdinov About Dr. Raul Gainetdinov Raul R. Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Gainetdinov was included in the Web of Science (WOS) Highly Cited Researchers (HCR) list, representing Raul Gainetdinov on the web Saint-Petersburg State University Wikipedia Google Scholar Researchgate Google

Paul J. Gasser About Dr. Paul J. Paul J.

Paul Insel turned dry-lab science into a reframing of COVID-19 pathobiology as a GPCR signaling imbalance — and a figure in The Economist. << Back to podcast list Strategic Partner(s) Paul Insel: Rethinking Paul Insel did something unusual for a working lab scientist: he stopped pipetting, and started writing Paul Insel "Almost most biological systems are all about gas pedals and brakes. Paul Insel "It's still about GPCRs." — Dr. Paul Insel About this episode Dr.

Paul Insel explains how unbiased GPCR expression profiling uncovered overlooked receptors in cancer — the field may need to rethink which GPCRs matter most. << Back to podcast list Strategic Partner(s) Paul Paul Insel's lab at UC San Diego has pursued this question using unbiased expression profiling — GPCR Paul Insel is Distinguished Professor of Pharmacology and Medicine at the University of California, San Paul Insel was at the FASEB experimental biology meeting in Atlantic City.

In 2010 he became a group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing

She trained in pharmacology at McGill University with Paul Clarke and completed postdoctoral work at Paul Clarck , where she studied opioid receptors.

During four years of postdoctoral research at ETH Zurich and the Paul Scherrer Institute in Switzerland Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr.

During her PhD with Paul Taghert at Washington University in St.

Paul Insel from UC San Diego — marking the beginning of hundreds of scientist-to-scientist conversations

It’s an eight-year-plus haul with built-in uncertainty.